Author

CH Barrios

Observed name: C.H. Barrios
Observed institutions: Université Paris-Sud, F. Hoffmann-La Roche AG, Universidad Complutense de Madrid, Alberta Health Services, Fox Chase Cancer Center, BC Cancer Agency, Guy's Hospital, Fukushima Medical University, Amgen (United States), Barwon Health, Sunnybrook Health Science Centre, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Queen Mary University of London, University of Calgary, Duke University, Universidade de São Paulo, University of California, San Francisco, Genentech, King's College London, University of Toronto, Guy's and St Thomas' NHS Foundation Trust, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Washington, Curtin University, Texas Oncology, Universitair Ziekenhuis Leuven, Peter MacCallum Cancer Centre, Auckland City Hospital, Odense University Hospital, Asan Medical Center, Hospital de Sant Pau, Jewish General Hospital, Institut Gustave Roussy, Hospital Universitari Arnau de Vilanova, University Hospital Heidelberg, University Hospital Complex Of Vigo, Baylor University Medical Center, Edinburgh Cancer Research, Rigshospitalet, Hospital General Universitario Gregorio Marañón, AC Camargo Hospital, Sorbonne Université, NYU Langone Health, Instituto de Oncología y Radiobiología, Massachusetts General Hospital, Instituto do Câncer do Estado de São Paulo, Utah Cancer Specialists, Osaka National Hospital, Hospital General Universitario Morales Meseguer, Comprehensive Cancer Center Vienna, Compass Oncology, Hospital de Clínicas de Porto Alegre, International Drug Development Institute (Belgium), Mount Vernon Cancer Centre, Institut za onkologiju i radiologiju Srbije, Centre Eugène Marquis, National Center for Tumor Diseases, Hospital Haroldo Juaçaba, Hospital Universitario Miguel Servet, Centro de Investigación Biomédica en Red, Hospital General Universitario de Elche, Dana-Farber Cancer Institute, Virginia Cancer Specialists, Instituto Nacional de Enfermedades Neoplásicas, Sisters of Charity Hospital, Duke Medical Center, Hospital General Universitario De Valencia, German Breast Group, Olive View-UCLA Medical Center, Aichi Cancer Center, Hospital São Lucas da PUCRS, Amgen (Switzerland), Sana Klinikum Offenbach, Lillebaelt Hospital, Instituto Nacional de Câncer - INCA, Faculdade de Medicina do ABC, Hospital Universitario de Valme, Hospital Universitario Virgen del Rocío, Instituto Nacional de Cancerología, Puma Biotechnology (United States), International Drug Development, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal, GEICAM – Spanish Breast Cancer Group, Centro de Pesquisas Oncológicas, Instituto Brasileiro de Controle do Câncer, Latin American Cooperative Oncology Group (LACOG), Cross Cancer Institute, Instituto de Seguridad Social del Estado de México y Municipios, Lady Davis Institute for Medical Research, Instituto de Investigación Sanitaria Gregorio Marañón, Odette Cancer Centre, Aichi Cancer Center Hospital, Pontifícia Universidade Católica do Rio Grande do Sul, McGill University, Medical University of Vienna, Ludwig-Maximilians-Universität München, Institute for Social Security and Services for State Workers, Universidade Federal de São Paulo, University of Sheffield, Tecnológico de Monterrey, University of Edinburgh
ORCID: 0000-0001-6021-667X
Observed ORCID: 0000-0001-6021-667X
OpenAlex ID: A5111655797
2019 · G Werutsky, C Villareal-Garza, et al. · Cancer Research
Works count: 24
Citation count: 191
H-index: 7
I10-index: 5
Year
Topic
Type